AAAAAA

   
Results: 1-9 |
Results: 9
PHARMACOKINETICS OF TERBINAFINE AND 5 KNOWN METABOLITES IN CHILDREN, AFTER ORAL-ADMINISTRATION
Authors: HUMBERT H DENOUEL J CABIAC MD LAKHDAR H SIOUFI A
Citation: H. Humbert et al., PHARMACOKINETICS OF TERBINAFINE AND 5 KNOWN METABOLITES IN CHILDREN, AFTER ORAL-ADMINISTRATION, Biopharmaceutics & drug disposition, 19(7), 1998, pp. 417-423
EVALUATION OF PHARMACOKINETIC STUDIES - IS IT USEFUL TO TAKE INTO ACCOUNT CONCENTRATIONS BELOW THE LIMIT OF QUANTIFICATION
Authors: HUMBERT H CABIAC MD BARRADAS J GERBEAU C
Citation: H. Humbert et al., EVALUATION OF PHARMACOKINETIC STUDIES - IS IT USEFUL TO TAKE INTO ACCOUNT CONCENTRATIONS BELOW THE LIMIT OF QUANTIFICATION, Pharmaceutical research, 13(6), 1996, pp. 839-845
HUMAN PHARMACOKINETICS OF DIHYDROERGOTAMINE ADMINISTERED BY NASAL SPRAY
Authors: HUMBERT H CABIAC MD DUBRAY C LAVENE D
Citation: H. Humbert et al., HUMAN PHARMACOKINETICS OF DIHYDROERGOTAMINE ADMINISTERED BY NASAL SPRAY, Clinical pharmacology and therapeutics, 60(3), 1996, pp. 265-275
PHARMACOKINETICS OF TERBINAFINE AND OF ITS 5 MAIN METABOLITES IN PLASMA AND URINE, FOLLOWING A SINGLE ORAL DOSE IN HEALTHY-SUBJECTS
Authors: HUMBERT H CABIAC MD DENOUEL J KIRKESSELI S
Citation: H. Humbert et al., PHARMACOKINETICS OF TERBINAFINE AND OF ITS 5 MAIN METABOLITES IN PLASMA AND URINE, FOLLOWING A SINGLE ORAL DOSE IN HEALTHY-SUBJECTS, Biopharmaceutics & drug disposition, 16(8), 1995, pp. 685-694
CONVERSION FROM CYCLOSPORINE SANDIMMUN TO CYCLOSPORINE NEORAL IN LIVER-TRANSPLANT PATIENTS WITH CHOLESTASIS OR EXTERNAL BILIARY DRAINAGE
Authors: FARGES O HADDAD N GIRAULT D CABIAC MD SAMUEL D BISMUTH H
Citation: O. Farges et al., CONVERSION FROM CYCLOSPORINE SANDIMMUN TO CYCLOSPORINE NEORAL IN LIVER-TRANSPLANT PATIENTS WITH CHOLESTASIS OR EXTERNAL BILIARY DRAINAGE, Transplantation proceedings, 27(4), 1995, pp. 2506-2507
PILOT-STUDY OF TERBINAFINE IN CHILDREN SUFFERING FROM TINEA-CAPITIS -EVALUATION OF EFFICACY, SAFETY AND PHARMACOKINETICS
Authors: NEJJAM F ZAGULA M CABIAC MD GUESSOUS N HUMBERT H LAKHDAR H
Citation: F. Nejjam et al., PILOT-STUDY OF TERBINAFINE IN CHILDREN SUFFERING FROM TINEA-CAPITIS -EVALUATION OF EFFICACY, SAFETY AND PHARMACOKINETICS, British journal of dermatology, 132(1), 1995, pp. 98-105
ELIMINATION KINETICS OF TERBINAFINE FROM HUMAN PLASMA AND TISSUES FOLLOWING MULTIPLE-DOSE ADMINISTRATION, AND COMPARISON WITH 3 MAIN METABOLITES
Authors: ZEHENDER H CABIAC MD DENOUEL J FAERGEMANN J DONATSCH P KUTZ K HUMBERT H
Citation: H. Zehender et al., ELIMINATION KINETICS OF TERBINAFINE FROM HUMAN PLASMA AND TISSUES FOLLOWING MULTIPLE-DOSE ADMINISTRATION, AND COMPARISON WITH 3 MAIN METABOLITES, Drug investigation, 8(4), 1994, pp. 203-210
STEADY-STATE PHARMACOKINETICS OF CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS - DOES AN INFLUENCE OF AGE OR BODY-WEIGHT EXIST
Authors: HUMBERT H GUEST G SAID MB CABIAC MD GAGNADOUX MF NIAUDET P BROYER M
Citation: H. Humbert et al., STEADY-STATE PHARMACOKINETICS OF CYCLOSPORINE IN RENAL-TRANSPLANT PATIENTS - DOES AN INFLUENCE OF AGE OR BODY-WEIGHT EXIST, Transplantation proceedings, 26(5), 1994, pp. 2791-2797
IN-VITRO IN-VIVO CORRELATION OF A MODIFIED-RELEASE ORAL FORM OF KETOTIFEN - IN-VITRO DISSOLUTION RATE SPECIFICATION
Authors: HUMBERT H CABIAC MD BOSSHARDT H
Citation: H. Humbert et al., IN-VITRO IN-VIVO CORRELATION OF A MODIFIED-RELEASE ORAL FORM OF KETOTIFEN - IN-VITRO DISSOLUTION RATE SPECIFICATION, Journal of pharmaceutical sciences, 83(2), 1994, pp. 131-136
Risultati: 1-9 |